pneumococcal disease

GSK acquiring Affinivax and its next-generation pneumonia vaccine for $2.1 billion upfront
BioPharma Dive
Tue, 05/31/22 - 10:53 am
GSK
M&A
Affinivax
vaccines
pneumococcal disease
Merck wins breakthrough therapy designation for potential pneumococcal vaccine successor
Endpoints
Thu, 04/14/22 - 10:43 am
Merck
vaccines
pneumococcal disease
V116
FDA
Merck, amid pneumococcal vaccine race with Pfizer, suffers FDA delay for key pediatric use
Fierce Pharma
Fri, 04/1/22 - 10:45 am
Merck
Pfizer
vaccines
pneumococcal disease
Vaxneuvance
FDA
pediatric
Sanofi aims to double vaccine sales by 2030, citing RSV and flu market expansion as key drivers
Fierce Pharma
Wed, 12/1/21 - 11:46 pm
Sanofi
vaccines
RSV
Flu
MRNA
pneumococcal disease
Bill and Melinda Gates Foundation backs little-known biotech going after Pfizer, Merck on pneumococcal vaccine
Endpoints
Wed, 11/10/21 - 09:38 pm
Gates Foundation
vaccines
Inventprise
IVT-25
pneumococcal disease
Pfizer, Merck next-gen pneumococcal vaccines score key CDC panel's backing on way to rival rollouts
Fierce Pharma
Thu, 10/21/21 - 11:20 pm
Pfizer
Merck
pneumococcal disease
vaccines
Prevnar 20
Vaxneuvance
CDC
Why Pfizer Will Profit From Merck's Rival Pneumococcal Vaccine
Motley Fool
Sat, 10/9/21 - 11:05 pm
Pfizer
Merck
vaccines
pneumococcal disease
Merck will pay royalties on next-gen pneumococcal shot to settle Pfizer patent fight
Fierce Pharma
Fri, 09/24/21 - 11:58 am
Merck
Pfizer
FDA
vaccines
pneumococcal disease
patents
Can Merck Beat Pfizer in This Multibillion-Dollar Vaccine Market?
Motley Fool
Sun, 08/1/21 - 11:50 pm
Merck
Pfizer
vaccines
Vaxneuvance
Prevnar 20
pneumococcal disease
Merck's Pneumococcal Vaccine Lands FDA Nod, Just Few Weeks After Its Rival
Benzinga
Mon, 07/19/21 - 10:55 am
Merck
vaccines
pneumococcal disease
Vaxneuvance
FDA
Pfizer
Prevnar 13
Pneumococcal Vaccine Snags Breakthrough Therapy Designation
BioSpace
Tue, 07/13/21 - 11:29 pm
Astellas
Affinivax
vaccines
pneumococcal disease
breakthrough therapy
Pfizer rolls out next-gen pneumococcal vaccine with FDA win, beating Merck's 15-valent candidate to the punch
Endpoints
Wed, 06/9/21 - 11:54 am
Pfizer
FDA
Merck
pneumococcal disease
vaccines
Prevnar 20
Merck, locked in next-gen pneumococcal vaccine race with Pfizer, strengthens its lead in childhood use
Fierce Pharma
Thu, 05/20/21 - 12:25 pm
Merck
Pfizer
pneumococcal disease
vaccines
V114
Prevnar 13 lags amid COVID-19 vaccine rollouts, but Pfizer sees a way to boost the franchise
Fierce Pharma
Tue, 05/4/21 - 10:38 pm
Pfizer
vaccines
Prevnar 13
pneumococcal disease
5 FDA approval decisions to watch in the second quarter
BioPharma Dive
Mon, 03/29/21 - 11:16 pm
FDA
Biogen
aducanumab
Acadia Pharmaceuticals
pimavanserin
AstraZeneca
vaccines
COVID-19
Sanofi
Avalglucosidase alfa
Pfizer
pneumococcal disease
Ready, set, pneumococcal vaccine: Pfizer teams up again with former football pro Terry Bradshaw
Fierce Pharma
Fri, 02/12/21 - 10:58 am
Pfizer
celebrity endorsements
vaccines
pneumococcal disease
Prevnar 13
Merck snags priority review for Prevnar 13 rival — just one month after Pfizer sent its follow-on to the FDA
Endpoints
Tue, 01/12/21 - 10:59 am
Merck
V114
pneumococcal disease
vaccines
FDA
priority review
Prevnar 13
Pfizer
Beating Merck, Pfizer gets priority review as the first Prevnar follow-up heads to the FDA
Endpoints
Wed, 12/9/20 - 10:41 am
Pfizer
20VPnC
Prevnar
pneumococcal disease
Merck
FDA
Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again
Fierce Biotech
Tue, 10/20/20 - 10:38 am
Merck
Pfizer
vaccines
Prevnar 13
clinical trials
V114
pneumococcal disease
Merck’s Experimental Pneumonia Vaccine Hits the Mark in Two Phase III Studies
BioSpace
Mon, 06/22/20 - 08:38 pm
Merck
vaccines
V114
clinical trials
HIV
pneumonia
pneumococcal disease

Pages